These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37665080)

  • 1. A comparison of different symptomatic reflux esophagitis treatments: A real-world study.
    Di Mario F; Crafa P; Franzoni L; Tursi A; Brandimarte G; Russo M; Rodriguez-Castro KI; Franceschi M; Bortoli N; Savarino E
    Adv Clin Exp Med; 2023 Sep; 32(9):1075-1080. PubMed ID: 37665080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review.
    Yadlapati R; Gyawali CP; Pandolfino JE;
    Clin Gastroenterol Hepatol; 2022 May; 20(5):984-994.e1. PubMed ID: 35123084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.
    Stefanidis G; Viazis N; Kotsikoros N; Tsoukalas N; Lala E; Theocharis L; Fassaris A; Manolakopoulos S
    Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27868281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of esophagus protection in complex treatment of erosive gastroesophageal reflux disease: a systematic review and meta-analysis of controlled trials].
    Bordin DS; Andreev DN; Maev IV
    Ter Arkh; 2023 Jan; 94(12):1407-1412. PubMed ID: 37167186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment efficacy of adding prokinetics to PPIs for gastroesophageal reflux disease: a meta-analysis.
    Xi L; Zhu J; Zhang H; Muktiali M; Li Y; Wu A
    Esophagus; 2021 Jan; 18(1):144-151. PubMed ID: 32519226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological treatment of children with gastro-oesophageal reflux.
    Tighe M; Afzal NA; Bevan A; Hayen A; Munro A; Beattie RM
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD008550. PubMed ID: 25419906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fixed combination of hyaluronic acid and chondroitin-sulphate oral formulation in a randomized double blind, placebo controlled study for the treatment of symptoms in patients with non-erosive gastroesophageal reflux.
    Palmieri B; Merighi A; Corbascio D; Rottigni V; Fistetto G; Esposito A
    Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3272-8. PubMed ID: 24379055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lansoprazole plus levosulpiride versus esomeprazole in participants with gastroesophageal reflux disease and erosive esophagitis: a double blinded randomized control trial.
    Umer MR; Mejia Crespo WE; Dugan S; Javed H; Suleman M; Afzal MW; Mumtaz H; Saqib M; Malik HM; Iftikhar M
    Ann Med Surg (Lond); 2023 Oct; 85(10):4866-4876. PubMed ID: 37811050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of the addition of prokinetics for proton pump inhibitor (PPI) resistant non-erosive reflux disease (NERD) patients: significance of frequency scale for the symptom of GERD (FSSG) on decision of treatment strategy.
    Miyamoto M; Manabe N; Haruma K
    Intern Med; 2010; 49(15):1469-76. PubMed ID: 20686276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient journey in gastroesophageal reflux disease: real-world perspectives from Italian gastroenterologists, primary care physicians, and ENT specialists.
    Pasta A; Pelizzaro F; Marabotto E; Calabrese F; Formisano E; Djahandideh Sheijani S; Brandimarte G; Manes G; Gravina AG; Savarino EV
    Therap Adv Gastroenterol; 2024; 17():17562848241239590. PubMed ID: 38524789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitors for functional dyspepsia.
    Pinto-Sanchez MI; Yuan Y; Hassan A; Bercik P; Moayyedi P
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011194. PubMed ID: 29161458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of prokinetics to PPI therapy in gastroesophageal reflux disease: a meta-analysis.
    Ren LH; Chen WX; Qian LJ; Li S; Gu M; Shi RH
    World J Gastroenterol; 2014 Mar; 20(9):2412-9. PubMed ID: 24605040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower esophageal sphincter injections for the treatment of gastroesophageal reflux disease.
    Watson TJ; Peters JH
    Thorac Surg Clin; 2005 Aug; 15(3):405-15. PubMed ID: 16104131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Esophagoprotective therapy in patients with erosive esophagitis].
    Bakulina NV; Tikhonov SV; Topalova YG; Ilchishina TA; Vasiliev RV
    Ter Arkh; 2022 Oct; 94(8):985-991. PubMed ID: 36286979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Systematic Review and Meta-analysis of Randomized Control Trials: Combination Treatment With Proton Pump Inhibitor Plus Prokinetic for Gastroesophageal Reflux Disease.
    Jung DH; Huh CW; Lee SK; Park JC; Shin SK; Lee YC
    J Neurogastroenterol Motil; 2021 Apr; 27(2):165-175. PubMed ID: 33795539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic Response to 20 mg of Esomeprazole Twice Daily in Patients with Gastroesophageal Reflux Disease-related Non-cardiac Chest Pain: An Open-Label Randomized Pilot Study].
    Choi JK; Shim HI; Shin CM; Yoon H; Park YS; Kim N; Lee DH
    Korean J Gastroenterol; 2020 Jun; 75(6):333-340. PubMed ID: 32581204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
    Schey R; Alla SP; Midani D; Parkman HP
    Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of pretreatment prediction of proton pump inhibitor (PPI)-resistant patients with gastroesophageal reflux disease and the dose escalation challenge of PPIs-TORNADO study: a multicenter prospective study by the Acid-Related Symptom Research Group in Japan.
    Furuta T; Shimatani T; Sugimoto M; Ishihara S; Fujiwara Y; Kusano M; Koike T; Hongo M; Chiba T; Kinoshita Y;
    J Gastroenterol; 2011 Nov; 46(11):1273-83. PubMed ID: 21861141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of three different dosages of esomeprazole in the long-term management of reflux disease: a prospective, randomized study, using the wireless Bravo pH system.
    Vasiliadis KV; Viazis N; Vlachogiannakos J; Sgouros SN; Stefanidis G; Archimandritis A; Karamanolis DG
    Am J Gastroenterol; 2010 Feb; 105(2):308-13. PubMed ID: 19809412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of esomeprazole in the treatment of gastroesophageal reflux disease (GERD).
    Kalaitzakis E; Björnsson E
    Ther Clin Risk Manag; 2007 Aug; 3(4):653-63. PubMed ID: 18472988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.